When was Geneoscopy founded?

Geneoscopy was founded in 2015 and raised its 1st funding round 1 year after it was founded.

Where is Geneoscopy located?

Geneoscopy is headquartered in St. Louis, United States.

How many employees does Geneoscopy have?

As of Sep 30, 2026, the latest employee count at Geneoscopy is 80.

Is Geneoscopy a funded company?

Geneoscopy is a funded company, having raised a total of $219M across 6 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Jun 22, 2016.

When was the latest funding round of Geneoscopy?

Geneoscopy's latest funding was a $***** Series C round on Jan 08, 2025, with participation from 9 investors.

Where does Geneoscopy rank among its competitors?

Geneoscopy ranks 1st amongst 403 active competitors, of which 134 are funded. It stands 4th in terms of total funding among its competitors. The most recent competitor to raise funding was 4baseCare, which secured an undisclosed amount in Jul, 2026.

Who are the top competitors of Geneoscopy?

Geneoscopy's top competitors include 4baseCare, Caris Life Sciences and Freenome Health. Among them, 4baseCare secured the most recent funding round in July, 2026.

Geneoscopy - 2026 Company Profile, Team, Funding & Competitors

Geneoscopy is a series C company based in St. Louis (United States), founded in 2015 by Erica Barnell. It operates as a Developer of non-invasive biomarker tests for colorectal cancer. Geneoscopy has raised $219M in funding from investors like Cultivation Capital, Billiken Angels Network and Bio Rad. The company has 403 active competitors, including 134 funded and 85 that have exited. Its top competitors include companies like 4baseCare, Caris Life Sciences and Freenome Health.

Company Details

Developer of non-invasive biomarker tests for colorectal cancer. The flagship assay analyzes stool samples for a panel of disease-associated mRNA biomarkers using a proprietary diagnostic algorithm to detect colorectal cancer. The company plans that its assay will be used to screen patients in need of a more invasive colonoscopy.

Website: geneoscopy.com
Social
Email ID: *****@gmail.com

Key Metrics

Founded Year

2015

Location

St. Louis, United States

Stage

Series C

Total Funding

$219M in 6 rounds

Latest Funding Round

Series C, Jan 08, 2025, $*****

Investors

Cultivation Capital & 19 more

Ranked

1^st among 403 active competitors

Employee Count

80 as on Sep 30, 2026

Similar Companies

4baseCare & 553 more

View Geneoscopy's full profile

Geneoscopy has raised a total funding of $219M over 6 rounds. Its first funding round was on Jun 22, 2016. Its latest funding round was a Series C round on Jan 08, 2025 for $*****. 9 investors participated in its latest round. Geneoscopy has 20 institutional investors.

Here is the list of recent funding rounds of Geneoscopy:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jan 08, 2025	7140029	Series C	8582183	5553185	9125377	1533817
Nov 16, 2021	5325948	Series B	5677427	3459030	2683895	LabCorp & 4 more
Nov 16, 2021	3369748	Conventional Debt	5824314	6129456	5428205	LightChain Capital & 6 more

Access funding benchmarks and valuations. Sign up today!

View details of Geneoscopy's funding rounds and investors

The founders of Geneoscopy is Erica Barnell.

Here are the details of Geneoscopy's key team members:

Erica Barnell: Founder & CEO of Geneoscopy.
Contact Info: 1 email address

View details of Geneoscopy's Founder profiles and Board Members

Geneoscopy's employee count trend

Geneoscopy has 80 employees as of Sep 26. Here is Geneoscopy's employee count trend over the years:

Uncover Geneoscopy's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Geneoscopy include 4baseCare, Caris Life Sciences and Freenome Health. Here is the list of Top 10 competitors of Geneoscopy, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Geneoscopy 2015, St. Louis (United States), Series C	Developer of non-invasive biomarker tests for colorectal cancer	$219M	Innovatus Capital Partners, PavLyfe & 18 others	67/100
2nd	4baseCare 2018, Bengaluru (India), Series B	Provider of precision oncology solutions, including genomic testing and digital health	$25.9M	Tremis Consultancy, Yali Capital & 41 others	67/100
3rd	Caris Life Sciences 1996, Irving (United States), Public	Developer of panomic disease profiling technologies for cancer precision medicine	$1.23B	Sixth Street, Coatue & 19 others	66/100
4th	Freenome Health 2014, United States, Series E	Provider of a deep learning platform for detecting circulating cancer-related markers	$1.35B	Perceptive Advisors, RA Capital Management ... & 65 others	66/100
5th	Intellia Therapeutics 2014, Cambridge (United States), Public	Developer of therapeutics based on CRISPR/Cas9 technology for multiple diseases	$85M	Atlas Venture, Novartis & 10 others	66/100
6th	NeoGenomics 2002, Fort Myers (United States), Public	Provider of cancer genetic diagnostic services	-	Ranger Investments, Aspen Capital & 1 others	63/100
7th	Deep Genomics 2014, Toronto (Canada), Series C	AI-powered platform for RNA biology to accelerate genetic therapy discovery	$238M	SoftBank Vision Fund, True Ventures & 16 others	62/100
8th	UniQure 1998, Amsterdam (Netherlands), Public	Developer of gene-based therapies for patients with genetic or acquired diseases	$111M	Gilde Healthcare, Advent Life Sciences & 11 others	62/100
9th	Personalis 2011, Menlo Park (United States), Acquired	Provider of genomic sequencing and diagnosis software for the healthcare industry	$87.3M	Abingworth, Lightspeed Venture Partners & 5 others	61/100
10th	GenSight Biologics 2011, Paris (France), Public	Developer of viral vector-based gene therapies for retinal neurodegenerative diseases	$76.6M	Perceptive Advisors, Fidelity Investments ... & 17 others	61/100